Morris Charles Q
SEC insider (Form 3/4/5 filer). CIK 0001489966. Chief Medical Officer at Prelude Therapeutics Inc (PRLD) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on May 1, 2026. Located in WILMINGTON, DE.
Companies Morris Charles Q has filed insider reports for
- Prelude Therapeutics Inc (PRLD): Officer, Chief Medical Officer
- LAVA Therapeutics NV (LVTX): Officer, Chief Medical Officer
Morris Charles Q
CIK: 0001489966
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
